JMP securities lowers Esperion Therapeutics Price Target to $4 (ESPR)

February 11, 2025 4:13 AM EST Send to a Friend
JMP Securities Jason N. Butler Market Outperform Esperion Therapeutics (NASDAQ: ESPR) price target of $4.00 (from $7.00).The analyst commented, “We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login